AAPL   381.92 (-0.21%)
MSFT   213.08 (-0.58%)
FB   241.74 (-1.13%)
AMZN   3,180.09 (-0.08%)
NVDA   423.60 (+0.77%)
MU   50.30 (+0.64%)
GE   6.67 (+1.37%)
TSLA   1,411.88 (+1.26%)
AMD   56.62 (-1.12%)
T   29.80 (+0.88%)
GILD   76.59 (+2.52%)
DIS   119.01 (+1.87%)
NFLX   527.47 (+3.88%)
BA   174.49 (+0.70%)
AAPL   381.92 (-0.21%)
MSFT   213.08 (-0.58%)
FB   241.74 (-1.13%)
AMZN   3,180.09 (-0.08%)
NVDA   423.60 (+0.77%)
MU   50.30 (+0.64%)
GE   6.67 (+1.37%)
TSLA   1,411.88 (+1.26%)
AMD   56.62 (-1.12%)
T   29.80 (+0.88%)
GILD   76.59 (+2.52%)
DIS   119.01 (+1.87%)
NFLX   527.47 (+3.88%)
BA   174.49 (+0.70%)
AAPL   381.92 (-0.21%)
MSFT   213.08 (-0.58%)
FB   241.74 (-1.13%)
AMZN   3,180.09 (-0.08%)
NVDA   423.60 (+0.77%)
MU   50.30 (+0.64%)
GE   6.67 (+1.37%)
TSLA   1,411.88 (+1.26%)
AMD   56.62 (-1.12%)
T   29.80 (+0.88%)
GILD   76.59 (+2.52%)
DIS   119.01 (+1.87%)
NFLX   527.47 (+3.88%)
BA   174.49 (+0.70%)
AAPL   381.92 (-0.21%)
MSFT   213.08 (-0.58%)
FB   241.74 (-1.13%)
AMZN   3,180.09 (-0.08%)
NVDA   423.60 (+0.77%)
MU   50.30 (+0.64%)
GE   6.67 (+1.37%)
TSLA   1,411.88 (+1.26%)
AMD   56.62 (-1.12%)
T   29.80 (+0.88%)
GILD   76.59 (+2.52%)
DIS   119.01 (+1.87%)
NFLX   527.47 (+3.88%)
BA   174.49 (+0.70%)
Log in

NASDAQ:SNESSenesTech Stock Price, Forecast & News

$2.01
-0.03 (-1.47 %)
(As of 07/10/2020 11:42 AM ET)
Add
Compare
Today's Range
$1.99
Now: $2.01
$2.02
50-Day Range
$1.55
MA: $1.93
$2.19
52-Week Range
$1.32
Now: $2.01
$36.20
Volume634 shs
Average Volume279,958 shs
Market Capitalization$6.81 million
P/E RatioN/A
Dividend YieldN/A
Beta2.06
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was founded in 2004 and is headquartered in Flagstaff, Arizona.
Read More
SenesTech logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.63 out of 5 stars


Industry, Sector and Symbol

Industry Agricultural chemicals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SNES
CUSIPN/A
Phone928-779-4143

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$140,000.00
Book Value$1.81 per share

Profitability

Net Income$-10,020,000.00
Net Margins-6,193.17%

Miscellaneous

Employees40
Market Cap$6.81 million
Next Earnings Date8/11/2020 (Estimated)
OptionableNot Optionable

Receive SNES News and Ratings via Email

Sign-up to receive the latest news and ratings for SNES and its competitors with MarketBeat's FREE daily newsletter.

SenesTech (NASDAQ:SNES) Frequently Asked Questions

How has SenesTech's stock been impacted by COVID-19 (Coronavirus)?

SenesTech's stock was trading at $2.48 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SNES shares have decreased by 19.8% and is now trading at $1.99. View which stocks have been most impacted by Coronavirus.

When is SenesTech's next earnings date?

SenesTech is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for SenesTech.

How were SenesTech's earnings last quarter?

SenesTech Inc (NASDAQ:SNES) released its earnings results on Friday, May, 15th. The company reported ($1.69) EPS for the quarter, missing the consensus estimate of ($1.46) by $0.23. The business earned $0.04 million during the quarter, compared to the consensus estimate of $0.05 million. SenesTech had a negative return on equity of 290.83% and a negative net margin of 6,193.17%. View SenesTech's earnings history.

When did SenesTech's stock split? How did SenesTech's stock split work?

SenesTech shares reverse split before market open on Wednesday, February 5th 2020. The 1-20 reverse split was announced on Tuesday, February 4th 2020. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 4th 2020. An investor that had 100 shares of SenesTech stock prior to the reverse split would have 5 shares after the split.

Has SenesTech been receiving favorable news coverage?

News articles about SNES stock have been trending positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. SenesTech earned a news impact score of 3.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news about SenesTech.

Are investors shorting SenesTech?

SenesTech saw a increase in short interest in June. As of June 30th, there was short interest totaling 19,000 shares, an increase of 322.2% from the June 15th total of 4,500 shares. Based on an average daily trading volume, of 311,400 shares, the short-interest ratio is presently 0.1 days. Approximately 0.6% of the shares of the company are short sold. View SenesTech's Current Options Chain.

Who are some of SenesTech's key competitors?

What other stocks do shareholders of SenesTech own?

Who are SenesTech's key executives?

SenesTech's management team includes the following people:
  • Dr. Loretta Powers Mayer, Co-Founder, Chair of the Board, CEO & Chief Scientific Officer (Age 70)
  • Dr. Cheryl Ann Dyer, Co-Founder, Pres & Chief Research Officer (Age 67)
  • Mr. Thomas C. Chesterman, Exec. VP, CFO, Treasurer & Assistant Sec. (Age 60)
  • Ms. Kim Wolin, Exec. VP of Operations & Sec. (Age 64)
  • Mr. Joe Malinowski, VP of Sales

When did SenesTech IPO?

(SNES) raised $15 million in an IPO on Thursday, December 8th 2016. The company issued 1,900,000 shares at a price of $8.00 per share. Roth Capital Partners served as the underwriter for the IPO and Craig-Hallum Capital Group was co-manager.

What is SenesTech's stock symbol?

SenesTech trades on the NASDAQ under the ticker symbol "SNES."

How do I buy shares of SenesTech?

Shares of SNES can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is SenesTech's stock price today?

One share of SNES stock can currently be purchased for approximately $1.99.

How big of a company is SenesTech?

SenesTech has a market capitalization of $6.75 million and generates $140,000.00 in revenue each year. The company earns $-10,020,000.00 in net income (profit) each year or ($7.69) on an earnings per share basis. SenesTech employs 40 workers across the globe.

What is SenesTech's official website?

The official website for SenesTech is www.senestech.com.

How can I contact SenesTech?

SenesTech's mailing address is 23460 NORTH 19TH AVENUE SUITE 110, PHOENIX AZ, 85027. The company can be reached via phone at 928-779-4143 or via email at [email protected]

This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.